ArticleVaccines2024
Safety and Tolerability of COVID-19 Vaccine in Mast Cell Disorders Real-Life Data from a Single Centre in Italy.
Stefania Nicola, Marina Mazzola, Luca Lo Sardo, Erika Montabone, Iuliana Badiu, Federica Corradi, Maria Carmen Rita Azzolina, Maurizio Gaspare Dall'Acqua, Giovanni Rolla, Irene Ridolfi and 2 more
Open access · goldAbstract read
In one paragraphArticle in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors at 2 institutions in 1 country.
Stefania NicolaSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Marina MazzolaSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.ORCID 0009-0000-2073-3082 Luca Lo SardoSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.ORCID 0009-0004-4201-3456 Erika MontaboneSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Iuliana BadiuSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Federica CorradiSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Maria Carmen Rita AzzolinaHealth Direction, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Maurizio Gaspare Dall'AcquaHealth Direction, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Giovanni RollaDepartment of Medical Sciences, University of Torino, C.so AM Dogliotti, 14, 10126 Torino, Italy.ORCID 0000-0001-5997-7172 Irene RidolfiDepartment of Medical Sciences, University of Torino, C.so AM Dogliotti, 14, 10126 Torino, Italy.
Anna QuinternettoSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.
Luisa BrussinoSCDU Immunologia e Allergologia, A.O. Ordine Mauriziano di Torino, C.so Re Umberto 109, 10128 Torino, Italy.ORCID 0000-0001-7249-7616 A. O. Ordine Mauriziano di Torino · ITUniversity of Turin · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
allergyCOVID-19epidemiologyhypersensitivity reactionmast cell disordersmastocytosispremedicationrisk assessmentsafetySARS-CoV-2tolerabilityvaccine
Identifiers
PMID38400185
PMCPMC10893122
OpenAlexW4391881892
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390